EvolutionaryScale’s Post

EvolutionaryScale reposted this

View profile for Andrew Dunn, graphic
Andrew Dunn Andrew Dunn is an Influencer

Senior Biopharma Correspondent at Endpoints News

Join me on October 16 for the first-ever *AI Day* at Endpoints News. I'm so excited for this event to come to life and for you to join. The virtual event is free and registration is now open — sign up at the link below. I'll talk with some of the most important scientific and industry leaders that are determining just how far AI can reshape the drug R&D industry. We'll discuss different approaches across big pharma and startups, as well as what lies beyond the AlphaFold breakthrough for protein language models. The day will start with a fireside chat with none other than David Baker, director of the Institute for Protein Design, University of Washington. Baker's lab has continuously put out cutting-edge work in predicting and designing proteins with AI. And, oh, he also recently cofounded Xaira Therapeutics, which launched this year with a mere $1 billion in committed funding. Other speakers announced: Amgen CTO David Reese, EvolutionaryScale cofounder & ex-Meta scientist Alex Rives, and Inceptive CEO & transformer pioneer Jakob Uszkoreit. Sign up now:

AI Day 2024

AI Day 2024

events.endpts.com

David Schull

President, Russo Partners, LLC

2mo

Thanks for sharing

Like
Reply
Mirna D.

Product Manager @ RID | Vice-chair @ YYC Data Society | Biophysical Chemist

3w

Tomas Tokar - maybe of interest?

Nancie Steinberg

Strategic Healthcare Integrated Marketing Communications Executive | Public Relations | Global Media Relations Professional | Pharma & Biotech | Life Sciences | Hospitals | Senior Vice President Media Relations | Speaker

2mo

Sounds great Andrew Dunn!

Like
Reply
See more comments

To view or add a comment, sign in

Explore topics